Pausa pranzo con poster - Società italiana di neurologia

9OTTOBRE•AREAPOSTER641. DECREASED CIRCULATING MIRNAS IN PATIENTS WITH MULTIPLESCLEROSISC. FENOGLIO, E. RIDOLFI, C. CANTONI, M. DE RIZ, A. PIETROBONI, M. SERPENTE,C. VILLA, R. BONSI, A. CALVI, L. PICCIO, A. CROSS, N. BRESOLIN, D. GALIMBERTI,E. SCARPINI (Milano, St. Louis - USA)642. STUDY OF ASSOCIATION BETWEEN NEUROTROPIC POLYOMAVIRUSESAND NEUROLOGIC DISORDERS, INCLUDING MULTIPLE SCLEROSISM. TOGNON, F. MARTINI, E. MAZZONI, S. PIETROBON, I. CASETTA, E. FAINARDI,M.CASTELLAZZI, E. GRANIERI (Ferrara)643. ERMES: EMILIA ROMAGNA MULTIPLE SCLEROSIS. REGIONAL NETWORKFOR IMPLEMENTING A BIOLOGICAL BANK TO IDENTIFY MARKERSOF DISEASE ACTIVITY RELATED TO CLINICAL VARIABLES.IDENTIFICATION OF CIRCULATING NONCLASSIC HUMAN LEUKOCYTEANTIGEN G (HLA-G) DIMER MOLECULES IN CEREBROSPINAL FLUIDSFROM MS STABLE PATIENTSR. RIZZO, D. BORTOLOTTI, A. ROTOLA, M. CASTELLAZZI, C. TAMBORINO, E. BALDI,M. TOLA, E. GRANIERI, O. BARICORDI, E. FAINARDI (Ferrara)644. THE TOXIC INFLUENCE OF ENVIRONMENTAL FACTORS IN MULTIPLESCLEROSIS:OBSERVATIONAL STUDY IN THE CAMPANIA REGIONG. LUS, A. SAGLIOCCHI, S. BONAVITA, G. ALFIERI, G. TEDESCHI (Napoli)645. DEMYELINATING DISORDERS AND HPV VACCINATION: A CASE REPORTA. PROTTI, V. PRONE, C. ERMINIO, C. BETTO, R. VACCARI, I. PICCOLO, G. VIGHI,E. AGOSTONI (Milano)646. CERULOPLASMIN AS A MARKER OF CHRONIC SYSTEMIC INFLAMMATIONIN RELAPSING-REMITTING MULTIPLE SCLEROSISS. VOLLARO, D. LANDI, R. SQUITTI, A. CONIGLIO, D. LUPOI, A. GHAZARYAN, E.FALATO, M. CORBETTO, P. PASQUALETTI, F. VERNIERI, M. FILIPPI (Roma)647. FAVORABLE OUTCOME OF PML IN A SICILIAN MULTIPLE SCLEROSISPATIENT TREATED WITH NATALIZUMABS. BUCELLO, G. CALLARI, B. PALMERI, R. COSTA, G. VITELLO, L. GRIMALDI (Cefalù- PA)648. IMMUNOMODULATORY MECHANISMS OF NATALIZUMAB IN MULTIPLESCLEROSISM. RUGGIERI, P. IAFFALDANO, M. MASTRAPASQUA, D. PAOLICELLI, M. TROJANO(Bari)649. ERMES: EMILIA ROMAGNA MULTIPLE SCLEROSIS. REGIONAL NETWORKFOR IMPLEMENTING A BIOLOGICAL BANK TO IDENTIFY MARKERSOF DISEASE ACTIVITY RELATED TO CLINICAL VARIABLES.IDENTIFICATION OF SERUM MICRORNAS AS MARKERS OF DISEASEACTIVITY IN MULTIPLE SCLEROSISS. SABBIONI, E. MIOTTO, M. FERRACIN, E. FAINARDI, M. CASTELLAZZI, C. BASSI, B.ZAGATTI, M. GENTILE, L. CANIATTI, R. TOLA, M. NEGRINI, E. GRANIERI (Ferrara)650. CSF CYTOLOGY IN CLINICALLY ISOLATED SYNDROME MAY PREDICTPROGRESSION TO MULTIPLE SCLEROSISY. MOTUZOVA, F. GRANIERI, P. VALENTINO, A. SALA, G. AMADORE, A. BERTOLOTTO(Minsk - BY, Orbassano - TO)651. IMMUNO-METABOLIC ASSET OF HISTORICAL HIGH-DOSESUBCUTANEOUS IFNB-1A TREATED MULTIPLE SCLEROSIS PATIENTSF. CARBONE, A. PAOLILLO, S. MONTELLA, P. CARRIERI, G. MATARESE (Napoli, Roma,Salerno)652. PROTEOMIC AND RED-OX PROTEOMIC ANALYSIS OF SERUM PROTEINSIN RELAPSING REMITTING MULTIPLE SCLEROSIS PATIENTST. KOUDRIAVTSEVA, E. ONESTI, E. BUCAJ, A. FIORINI, E. SBARDELLA, M. MINGOIA,F. DE MARCO, M. PERLUIGI (Roma)182